Holds one active US DMF and one valid CEP for captopril, filing since 1996. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for captopril, filing since 2017. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 7 markets.
Holds one active US DMF and one valid CEP for captopril, filing since 1999. Its 2025 FDA inspection closed as OAI, and its GMP is recognised in 1 market.
Holds 3 active US DMFs for captopril, filing since 2019. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for captopril, filing since 1990. Its 2023 FDA inspection closed as VAI.
Registered with DAV (Vietnam) for captopril. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for captopril. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for captopril. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for captopril. Its GMP is recognised in 1 market.
Registered with DAV (Vietnam) for captopril.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for freeFixed-dose combinations containing captopril. Each page leads with the verified API makers of every component.